What is the size of the Global Molecular Genetic Testing for Autoimmune Diseases Market?

The Global Molecular Genetic Testing for Autoimmune Diseases Market was valued at USD 700 million and is projected to reach a market size of USD 984.97 million by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 5%.

Which is the most dominant region for the Global Molecular Genetic Testing for Autoimmune Diseases Market?

North America is the most dominant region for the Global Molecular Genetic Testing for Autoimmune Diseases Market.

Who are the leading players in the Global Molecular Genetic Testing for Autoimmune Diseases Market?

Abbott Laboratories, Thermo Fisher Scientific, and Illumina are the key players operating in the Global Molecular Genetic Testing for Autoimmune Diseases Market.

Global Molecular Genetic Testing for Autoimmune Diseases Market | Size, overview, trends, and forecast

Q: What are the Global Molecular Genetic Testing for Autoimmune Diseases Market drivers?

An increasing prevalence of diseases and technological advancements are the main factors propelling the Global Molecular Genetic Testing for Autoimmune Diseases Market.

Q: What are the segments under the Global Molecular Genetic Testing for Autoimmune Diseases Market by Disease Type?

Based on Disease Type, the Global Molecular Genetic Testing for Autoimmune Diseases Market is segmented into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Type 1 Diabetes, Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), and Others.